African ancestry and genetic risk for uterine leiomyomata

American Journal of Epidemiology

Volumn 176, Issue 12, 2012, Pages 1159-1168

  Wise, Lauren A ^a   Ruiz Narvaez, Edward A ^a   Palmer, Julie R ^a   Cozier, Yvette C ^a   Tandon, Arti ^b,c   Patterson, Nick ^c   Radin, Rose G ^a   Rosenberg, Lynn ^a   Reich, David ^b  

^a BOSTON UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

African Americans; African continental ancestry group; European continental ancestry group; female; genetics; leiomyoma; prospective studies; uterine neoplasms

Indexed keywords

DNA;

AFRICAN AMERICAN; ANCESTRY; BLACK POPULATION; CHROMOSOME; ETHNIC CONFLICT; GENETIC ANALYSIS; HEALTH SURVEY; POLYMORPHISM; SPATIOTEMPORAL ANALYSIS; WOMENS HEALTH;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ARTICLE; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENE LOCUS; GENE MAPPING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HUMAN; INCIDENCE; JAPANESE; MAJOR CLINICAL STUDY; PROSPECTIVE STUDY; REPLICATION STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; UTERUS MYOMA;

ADULT; AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC LOAD; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HEALTH STATUS DISPARITIES; HUMANS; JAPAN; LEIOMYOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE; PROSPECTIVE STUDIES; RISK; UNITED STATES; UTERINE NEOPLASMS;

UNITED STATES;

EID: 84871181696     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws276     Document Type: Article

References (41)

1. Buttram VC, Reiter RC. Uterine leiomyomata: etiology, symptomatology, and management. Fertil Steril. 1981;36(4): 433-445.
2. Coronado GD, Marshall LM, Schwartz SM. Complications in pregnancy, labor, and delivery with uterine leiomyomas: a population-based study. Obstet Gynecol. 2000;95(5):764-769.
3. Stewart EA. Uterine fibroids. Lancet. 2001;357(9252): 293-298.
4. Marshall LM, Spiegelman D, Barbieri RL, et al. Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol. 1997;90(6): 967-973.
5. Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1): 100-107.
6. Kjerulff KH, Guzinski GM, Langenberg PW, et al. Hysterectomy and race. Obstet Gynecol. 1993;82(5):757-764.
7. Kjerulff KH, Langenberg P, Guzinski GM. The socioeconomic correlates of hysterectomies in the United States. Am J Public Health. 1993;83(1):106-108.
8. Kjerulff KH, Langenberg P, Seidman JD, et al. Uterine leiomyomas: racial differences in severity, symptoms, and age at diagnosis. J Reprod Med. 1996;41(7):483-490.
9. Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect. 2000;108(suppl 5): 821-827.
10. Stewart EA, Morton CC. The genetics of uterine leiomyomata: what clinicians need to know. Obstet Gynecol. 2006;107(4):917-921.
11. Vikhlyaeva EM, Khodzhaeva ZS, Fantschenko ND. Familial predisposition to uterine leiomyomas. Int J Gynaecol Obstet. 1995;51(2):127-131.
12. Schwartz S, Voigt L, Tickman E, et al. Familial aggregation of uterine leiomyomata [abstract]. Am J Epidemiol. 2000; 151(suppl):S10.
13. Kurbanova MKH, Koroleva AG, Sergeev AS. Genetic analysis of the predisposition to uterine myoma: prevalence and morbidity. Genetika. 1989;25(6):1122-1124.
14. Kurbanova MKH, Koroleva AG, Sergeev AS. Geneticepidemiologic analysis of uterine myoma: assessment of repeated risk. Genetika. 1989;25(10):1896-1898.
15. Treloar SA, Martin NG, Dennerstein L, et al. Pathways to hysterectomy: insights from longitudinal twin research. Am J Obstet Gynecol. 1992;167(1):82-88.
16. Luoto R, Kaprio J, Rutanen EM, et al. Heritability and risk factors of uterine fibroids-the Finnish Twin Cohort study. Maturitas. 2000;37(1):15-26.
17. Reed WB, Walker R, Horowitz R. Cutaneous leiomyomata with uterine leiomyomata. Acta Derm Venereol. 1973;53(5): 409-416.
18. Garcia Muret MP, Pujol RM, Alomar A, et al. Familial leiomyomatosis cutis et uteri (Reed's syndrome). Arch Derm Res. 1988;280(suppl):S29-S32.
19. Launonen V, Vierimaa O, Kiuru M, et al. Inherited susceptibility to uterine leiomyomas and renal cell cancer. Proc Natl Acad Sci USA. 2001;98(6):3387-3392.
20. Cha PC, Takahashi A, Hosono N, et al. A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids. Nat Genet. 2011;43(5): 447-450.
21. Van Voorhis BJ, Romitti PA, Jones MP. Family history as a risk factor for development of uterine leiomyomas: results of a pilot study. J Reprod Med. 2002;47(8):663-669.
22. Gross K, Morton C, Stewart EA. Finding genes for uterine fibroids [abstract]. Obstet Gynecol. 2000;95(4 suppl):S60.
23. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273(5281):1516-1517.
24. Patterson N, Hattangadi N, Lane B, et al. Methods for highdensity admixture mapping of disease genes. Am J Hum Genet. 2004;74(5):979-1000.
25. Rosenberg L, Adams-Campbell LL, Palmer JR. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc. 1995;50(2): 56-58.
26. Cozier YC, Palmer JR, Rosenberg L. Comparison of methods for collection of DNA samples by mail in the Black Women's Health Study. Ann Epidemiol. 2004;14(2):117-122.
27. Dueholm M, Lundorf E, Hansen ES, et al. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol. 2002;186(3): 409-415.
28. Loutradis D, Antsaklis A, Creatsas G, et al. The validity of gynecological ultrasonography. Gynecol Obstet Invest. 1990;29(1):47-50.
29. Wise LA, Palmer JR, Stewart EA, et al. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynecol. 2005;105(3):563-568.
30. Fan JB, Oliphant A, Shen R, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol. 2003;68: 69-78.
31. Ruiz-Narvaez EA, Rosenberg L, Wise LA, et al. Validation of a small set of ancestral informative markers for control of population admixture in African Americans. Am J Epidemiol. 2011;173(5):587-592.
32. SAS Institute Inc. SAS/STAT 9.2 User's Guide. Cary, NC: SAS Institute Inc; 2008.
33. Hoggart CJ, Parra EJ, Shriver MD, et al. Control of confounding of genetic associations in stratified populations. Am J Hum Genet. 2003;72(6):1492-1504.
34. McKeigue PM, Carpenter JR, Parra EJ, et al. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations. Ann Hum Genet. 2000;64(2):171-186.
35. Hoggart CJ, Shriver MD, Kittles RA, et al. Design and analysis of admixture mapping studies. Am J Hum Genet. 2004;74(5):965-978.
36. Shlush LI, Bercovici S, Wasser WG, et al. Admixture mapping of end stage kidney disease genetic susceptibility using estimated mutual information ancestry informative markers. BMC Med Genomics. 2010;3:47. (doi:10.1186/1755- 8794-1183-1147).
37. Lind JM, Hutcheson-Dilks HB, Williams SM, et al. Elevated male European and female African contributions to the genomes of African American individuals. Hum Genet. 2007;120(5):713-722.
38. Breslow NE, Day NE. Statistical Methods in Cancer Research. Vol 2. The Design and Analysis of Cohort Studies. (IARC Scientific Publication no. 82). Lyon, France: IARC Press; 1987:1-406.
39. Freedman ML, Haiman CA, Patterson N, et al. Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA. 2006; 103(38):14068-14073.
40. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40(10):1185-1192.
41. Haiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet. 2007;39(5):638-644.